Company facts
- Headquarters
- Irvine, California
- Most recent report
- 8-K, filed Aug 28, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1099800
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 30
News 8 of 59
Prospectuses and Registrations 8 of 9
- S-8 Registration statement for an employee plan Aug 4, 2026
- S-8 Registration statement for an employee plan Aug 6, 2025
- S-8 Registration statement for an employee plan Aug 6, 2025
- S-3ASR Automatic shelf registration Jul 21, 2025
- S-8 Registration statement for an employee plan Jul 31, 2024
- S-3ASR Automatic shelf registration Jul 22, 2022
- S-8 Registration statement for an employee plan May 7, 2021
- S-8 Registration statement for an employee plan May 7, 2021
Proxies 8 of 25
- DEFA14A Extra proxy material Mar 26, 2026
- DEFA14A Extra proxy material Mar 26, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 26, 2026
- DEFA14A Extra proxy material Apr 14, 2025
- DEFA14A Extra proxy material Mar 26, 2025
- DEFA14A Extra proxy material Mar 26, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 26, 2025
- DEFA14A Extra proxy material Mar 26, 2024
Ownership 8 of 846
- 4 Insider reported a trade Aug 31, 2026
- 144 Notice of a proposed sale of restricted stock Aug 31, 2026
- 4 Insider reported a trade Aug 28, 2026
- 144 Notice of a proposed sale of restricted stock Aug 28, 2026
- 4 Insider reported a trade Aug 26, 2026
- 4 Insider reported a trade Aug 26, 2026
- 144 Notice of a proposed sale of restricted stock Aug 26, 2026
- 144 Notice of a proposed sale of restricted stock Aug 26, 2026
Other 8 of 31
- 11-K Employee stock plan report Jun 12, 2026
- 11-K Employee stock plan report Jun 12, 2026
- SD Conflict minerals disclosure May 27, 2026
- ARS Annual report sent to shareholders Mar 26, 2026
- 11-K Employee stock plan report Jun 17, 2025
- 11-K Employee stock plan report Jun 17, 2025
- SD Conflict minerals disclosure May 30, 2025
- ARS Annual report sent to shareholders Mar 26, 2025
What to read: Jun 2026 10-Q
SECSift found 2 of 11 sections worth reading, with 1 positive, 6 notable, and 4 negative flags.
Financial Statements (Item 1)
Tax rate jump to 53.6%, new IRS proposals >$1.8B, consolidations, impairments all hit earnings.Notable- Consolidated a VIE in May 2026, adding $139.6M goodwill, $161.5M in-process R&D, and $112.4M noncontrolling interest.
- Acquired Autus in Feb 2026 for $128.9M, with $102.9M IPR&D and up to $132.5M milestone payments.
- Securities class action settled preliminarily for immaterial amount; expense recorded in H1 2026.
Management's Discussion (Item 2)
IRS disputes targeting $2B+, tax rate spike from $188.2M CA valuation allowance, large impairment.Notable- Litigation expenses rose to $43.4M in H1 2026 (vs $26.4M), and Pillar Two expected to add ~$50M tax in 2026 before offsets.
- Repurchased 6.9M shares for $558.7M in H1 2026 (including $500M accelerated agreement); $1.5B remaining authorization.
- Operating cash flow H1 2026 was $695.7M, up $125.1M; no debt drawn on $750M credit facility; cash $4.2B total.
What changed: Jun 2026 vs. Mar 2026
About 12% of EW's Jun 2026 10-Q is new information. 31 paragraphs were added, 113 changed, and 20 removed. Below are the most important lines SECSift identified.
Changed
Everything here comes from Edwards Lifesciences Corp's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Aug 19, 2026, from the 10-Q for Jun 2026.